Cell-free DNA (cfDNA) is a noninvasive and informative disease biomarker, providing relevant information regarding disease characteristics and origins. Its use in clinical diagnostics was previously limited, but recent improvements in automation and high-throughput screening machinery allow scientists to classify cfDNA rapidly in large patient populations.
Download this poster from Tecan to discover how technological innovation enables faster cfDNA-mediated diagnosis.
Top Image Credit:
istock
The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.
View this Issue
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
In this webinar, Andre Mueller will discuss how scientists characterize therapeutic proteins in different formulations and spot the effects of excipients on protein stability.
A streamlined, automated process helps scientists coordinate site-ready production-level whole genome sequencing results.
System strengthens Taiwan’s capabilities in protein drug discovery research
The Transferpette® pro expands the Transferpette® family, offering scientists even greater flexibility to match their pipetting preferences and workflow requirements.
Fast, gentle, and highly specific glycoprotein labeling compatible with downstream immunofluorescence, enabled by next-generation aminooxy chemistry.
Thermo Scientific X and S Series General Purpose Centrifuges are designed to help provide exceptional performance, versatility and enhanced sustainability.
